Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects.
about
Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviewsAdverse events associated with single-dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviewsImpact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer painPatient considerations and drug selection in the treatment of idiopathic pulmonary fibrosisLessons learned from placebo groups in antidepressant trialsFocus on headache as an adverse reaction to drugsCatechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responsesAssessing general side effects in clinical trials: reference data from the general population.Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines.Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trialConscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients.The nocebo effect and its relevance for clinical practice.Nonspecific adverse events in knee osteoarthritis clinical trials: a systematic review.To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent.Nocebo phenomena in medicine: their relevance in everyday clinical practice.The nocebo effect of drugs.Randomized controlled trials: who fails run-in?Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.Explaining attitudes and adherence to antipsychotic medication: the development of a process model.The nocebo effect: a clinicians guide.Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).Adverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns.Risk factors for self-reported adverse drug events among Medicare enrollees.Patient-reporting of side effects may provide an important source of information in clinical practice.Patients' Expectations Predict Surgery Outcomes: A Meta-Analysis.Nocebo and pain: An overview of the psychoneurobiological mechanisms.
P2860
Q24186666-DCC95772-4047-414F-845F-38484CF3EDA2Q24192963-99BE3317-E044-45E4-99AA-0012A38700C9Q24194524-B6E7D721-2CCF-4F89-8A73-02C97899D855Q26750418-F16CDA77-F044-42A7-BB0A-3A60E8868235Q28478927-3305463E-F0A5-437B-A117-C8FDB03C1238Q28483956-349E8ADD-F838-4AB2-92DA-72FC459D64E3Q28542991-7D686917-343E-47E8-8ED3-CE93D8D9A8A4Q33856964-8E9FD215-B3F1-4E47-9B35-DEE5FCDE262CQ34131674-810CFF3F-39C9-4CC6-8555-48CCC5286C6FQ34991931-D8C68F86-6B72-47B4-BDAA-59A29E5FA8CDQ35063000-F7B75531-EBDC-40AE-BCC5-AF6633F071B0Q35196454-CA5F15A1-0A55-439D-9C20-A2A1016C6962Q35387933-F9FB6F30-F7EB-48AB-9010-BD46FE73FFF2Q35961965-097A3804-3FF4-4E34-A2DD-317488E9243FQ36108284-04822E14-D406-4FB1-BFA8-27021D4E41B2Q36719631-B54E6FAC-4D0B-40EE-9393-D8355C1D4BE2Q37138840-FD084C14-F50F-4DB8-B57B-0DC5C91A1CB7Q37578354-082ACA9F-0310-40A8-A58C-263D94397E91Q37623597-8A694DEE-646D-40D6-A9E6-029880360F9FQ38055026-CF3AF2A8-359F-4B8D-B624-93E62105EDB0Q38259757-0EDC208B-DEF1-4D0A-8322-5726A63E0489Q38702563-E0805E7B-B3DF-42DF-8E95-31AE3DE73146Q39447168-59FB3F87-CCA3-4982-B024-9D1F09B78465Q40151970-794B8989-718B-4130-AE51-EF449F722561Q42609701-3C4ADBF1-B366-45BE-8E12-53ADD1BFC281Q48000036-11380195-CC69-4C58-A735-6E7A7263D08CQ49635898-EA16C284-EC00-46F9-83EA-4DF1FC60740C
P2860
Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Medication-attributed adverse ...... assessment of adverse effects.
@ast
Medication-attributed adverse ...... assessment of adverse effects.
@en
type
label
Medication-attributed adverse ...... assessment of adverse effects.
@ast
Medication-attributed adverse ...... assessment of adverse effects.
@en
prefLabel
Medication-attributed adverse ...... assessment of adverse effects.
@ast
Medication-attributed adverse ...... assessment of adverse effects.
@en
P1476
Medication-attributed adverse ...... assessment of adverse effects.
@en
P2093
Arthur J Barsky
Jerry Avorn
P304
P356
10.1001/ARCHINTE.166.2.155
P407
P577
2006-01-01T00:00:00Z